Activated protein C in acute pancreatitis - A double-blind, randomized, placebo-controlled study;Aktiviertes Protein C bei akuter Pankreatitis eine doppelblinde, randomisierte, Placebo-kontrollierte Studie

Medizinische Klinik

Volumn 105, Issue 10, 2010, Pages 747-

  Weismann, Dirk ^a   Maier, Sebastian K G ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTEIN C; DROTRECOGIN; PLACEBO;

ACUTE PANCREATITIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG RESPONSE; HUMAN; NOTE; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

EID: 78649359496     PISSN: 07235003     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00063-010-1127-3     Document Type: Note

References (5)

1. Halonen KI, Pettila V, Leppaniemi AK et al. (2002) Multiple organ dysfunction associated with severe acute pancreatitis. Crit Care Med 30:1274-1279.
2. Nathens AB, Curtis JR, Beale RJ et al. (2004) Management of the critically ill patient with severe acute pancreatitis. Crit Care Med 32:2524-2536.
3. Pettila V, Kyhala L, Kylanpaa ML et al. (2010) APCAP - activated protein C in acute pancreatitis: a double-blind randomized human pilot trial. Crit Care 14: R139.
4. Shankar-Hari M, Wyncoll D (2010) Activated protein C in severe acute pancreatitis without sepsis? Not just yet. Crit Care 14:188.
5. Yamanel L, Mas MR, Comert B et al. (2005) The effect of activated protein C on experimental acute necrotizing pancreatitis. Crit Care 9: R184-190.